Trial Profile

The predictive value of the acute effect of montelukast on an exercise challenge test for the outcome of longterm treatment with montelukast.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 14 Aug 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Montelukast (Primary)
Indications Allergic asthma; Bronchoconstriction; Exercise-induced asthma
Focus Therapeutic Use
Acronyms SD-MLK

Most Recent Events

13 Jul 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record
28 Mar 2012 Actual initiaiton date 22 Apr 2010 adde as reported by European Clinical Trials Database.
28 Mar 2012 Status changed from planning to recruiting as reported by European Clinical Trials Database.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com